Scarica l'app Stockscreener
424.53
2.42%
-10.51
Pre-mercato:
422.01
-2.52
-0.59%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ELV Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$435.04
Aprire:
$390
Volume 24 ore:
3.57M
Relative Volume:
2.16
Capitalizzazione di mercato:
$99.88B
Reddito:
$176.81B
Utile/perdita netta:
$5.98B
Rapporto P/E:
16.58
EPS:
25.61
Flusso di cassa netto:
$4.55B
1 W Prestazione:
-2.71%
1M Prestazione:
-1.41%
6M Prestazione:
-4.46%
1 anno Prestazione:
-16.59%
Intervallo 1D:
$390.00
$437.99
Intervallo di 1 settimana:
$390.00
$443.29
Portata 52W:
$362.21
$567.26
Elevance Health Inc Stock (ELV) Company Profile
Nome
Elevance Health Inc
Settore
Industria
Telefono
(800) 331-1476
Indirizzo
220 VIRGINIA AVENUE, INDIANAPOLIS
Confronta ELV con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ELV
Elevance Health Inc
|
424.53 | 99.88B | 176.81B | 5.98B | 4.55B | 25.61 |
|
UNH
Unitedhealth Group Inc
|
454.11 | 536.99B | 410.06B | 22.11B | 24.86B | 23.88 |
|
CI
Cigna Group
|
330.13 | 89.25B | 244.38B | 3.43B | 8.96B | 12.24 |
|
CVS
Cvs Health Corp
|
67.29 | 87.36B | 372.81B | 4.61B | 6.33B | 3.66 |
|
HUM
Humana Inc
|
264.48 | 34.38B | 117.76B | 1.21B | 2.39B | 9.95 |
Elevance Health Inc Stock (ELV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-15 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2025-03-17 | Aggiornamento | Argus | Hold → Buy |
| 2025-01-22 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2024-10-18 | Downgrade | Argus | Buy → Hold |
| 2024-07-18 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-06-24 | Iniziato | Morgan Stanley | Overweight |
| 2024-05-30 | Iniziato | Robert W. Baird | Outperform |
| 2024-03-06 | Iniziato | Barclays | Overweight |
| 2023-07-12 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2023-04-27 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-03-28 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-09-09 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-08-22 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
Mostra tutto
Elevance Health Inc Borsa (ELV) Ultime notizie
Elevance Health preannounced Q1 earnings beat ‘quite positive,’ says Baird - Yahoo Finance
Will a Strong MA Business Aid Elevance Health's Q1 Earnings? - MSN
Elevance Health's Preliminary Q1 Earnings Help Ease Market Concerns, Truist Says - MarketScreener
UnitedHealth Casts Gloom Over Insurers After Shock Forecast Cut - Bloomberg.com
MU Health 'out of network' for Elevance Health/Anthem patients after insurer fails to reach agreement - Read Lion
Elevance Health Expects Q1 Earnings Above Estimates, Retains Full-Year Guidance: But Retail’s Pessimistic - Investing.com India
Elevance Health (ELV) Surpasses Q1 Earnings Projections, Maintains Full-Year Outlook - GuruFocus
Elevance Maintains Profit Guidance After UnitedHealth Cut - Bloomberg.com
Elevance Health's Preliminary Q1 Adjusted Net Income Rises - marketscreener.com
CVS, Humana and Elevance Shares Are Trading Lower Thursday: What's Going On? - Benzinga
Elevance Health projects steady Q1 results, confirms 2025 outlook - Investing.com
Elevance Health stock in focus after Q1 outlook (ELV:NYSE) - Seeking Alpha
Elevance Health Projects Q1 2025 Earnings Expectations - TipRanks
Elevance Health projects steady Q1 results, confirms 2025 outlook By Investing.com - Investing.com South Africa
Elevance maintains profit forecast after rival UnitedHealth's outlook cut - Reuters
Elevance Health (ELV) to Announce Q1 2025 Earnings on April 22 | ELV Stock News - GuruFocus
Elevance Health (ELV) to Announce Q1 2025 Financial Results on April 22 | ELV Stock News - GuruFocus
Health insurer Elevance sees first-quarter profit above estimates - marketscreener.com
Ahead of Elevance Health (ELV) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics - Yahoo Finance
Anthem Strikes Deal To End Mental Health Class Action - Law360
Baird Downgrades Elevance Health (BIT:1ANTM) - Nasdaq
Elevance Health (NYSE:ELV) Faces Shareholder Proposal on Diversity and Inclusion Reporting - Yahoo Finance
Morgan Stanley Adjusts Elevance Health Price Target to $428 From $405, Maintains Equal Weight Rating - MarketScreener
Elevance Health (NYSE:ELV) stock performs better than its underlying earnings growth over last five years - Yahoo Finance
Elevance Health (ELV) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance
How Do Investors Really Feel About Elevance Health? - Benzinga
Implied Volatility Surging for Elevance Health (ELV) Stock Options - Yahoo Finance
Morgan Stanley Adjusts Price Target for Elevance Health (ELV) to $428 | ELV Stock News - GuruFocus
Elevance Health (ELV) Downgraded by Baird Amid Policy Uncertaint - GuruFocus
Elevance Health: A Hidden Gem Amongst Healthcare Turbulence - Seeking Alpha
5 of the Safest Stocks Billionaire Money Managers Bought Ahead of Wall Street's Historic Volatility - The Motley Fool
Truist Increases Price Target for Elevance Health (ELV) Ahead of Q1 Results | ELV Stock News - GuruFocus
Elevance Health, Inc. (ELV): Among the Best Medical Stocks to Buy According to Billionaires - Insider Monkey
Truist Securities Raises Price Target on Elevance Health to $510 From $480, Keeps Buy Rating - MarketScreener
Elevance Health, Inc.'s (NYSE:ELV) Stock Is Going Strong: Is the Market Following Fundamentals? - Yahoo
Elevance Beats Teacher's Bias Suit Over Weight Loss Drugs - Law360
Guggenheim Initiates Coverage of Elevance Health (BMV:ELV) with Buy Recommendation - Nasdaq
Guggenheim Initiates Coverage of Elevance Health (WBAG:ELV) with Buy Recommendation - Nasdaq
Guggenheim Initiates Coverage of Elevance Health (BIT:1ANTM) with Buy Recommendation - Nasdaq
Elevance Beats Bias Claim Over Plan's Weight Loss Drug Exclusion - Bloomberg Law News
Elevance Health (ELV) is Rebounding From Sell Off - Insider Monkey
Guggenheim Initiates Coverage of Elevance Health (ELV) with Buy Recommendation - Nasdaq
Jared Moskowitz trades in Broadcom and Elevance Health stocks, buys into NVIDIA, SPDR Gold Trust, and TJX Companies - Investing.com India
5 Analysts Assess Elevance Health: What You Need To Know - Benzinga
Elevance Health Women's Fort Myers Tip-Off comes to Scripps Sports, ION in multiyear agreement - Yahoo Finance
Guggenheim Initiates Elevance Health at Buy With $518 Price Target - marketscreener.com
Guggenheim sets Elevance stock Buy rating with $518 target By Investing.com - Investing.com India
Guggenheim sets Elevance stock Buy rating with $518 target - Investing.com
US health insurers jump as 2026 Medicare payment rates exceed expectations - Reuters
Health Insurers Surge After Medicare Agency Increases Payment Rates - Benzinga
US releases final Medicare payment rates for 2026 - MarketScreener
Elevance Health Inc Azioni (ELV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.21%
1.84%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):